Skip to main content
. 2021 Sep 29;16(9):e0250539. doi: 10.1371/journal.pone.0250539

Table 5. Treatments for high vs. low RNLS levels in patients with locally advanced/borderline resectable pancreatic adenocarcinoma as compared to CA19-9.

RNLS
Factor Low (n = 38) High (n = 38) aOR (95%CI) p-value
Resection 13 (34.2%) 5 (13.2%) 0.29 (0.09–0.93) 0.036
Chemotherapy 36 (94.7%) 36 (97.3%) 2.00 (0.17–23.06) 0.578
Radiotherapy 18 (48.6%) 21 (58.3%) 1.48 (0.59–3.73) 0.408
CA19-9
Factor Low (n = 14) High (n = 8) aOR (95%CI) p-value
Resection 3 (42.9%) 3 (20.0%) 0.33 (0.05–2.37) 0.272
Chemotherapy 6 (85.7%) 15 (100.0%) -- 1.000
Radiotherapy 5 (71.4%) 7 (46.7%) 0.35 (0.05–2.41) 0.286